Stock ANIP ANI PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
65.36 USD +0.63% Intraday chart for ANI Pharmaceuticals, Inc. -0.18% +18.53%
04-17 Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing MT
04-09 ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing
Sector Update: Health Care Stocks Decline Late Afternoon
Sector Update: Health Care Stocks Retreat Thursday Afternoon
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
ANI Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2024
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Ani Pharmaceuticals Insider Sold Shares Worth $1,416,466, According to a Recent SEC Filing
ANI Pharmaceuticals Launches Pentoxifylline Extended-Release Tablets
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
Ani Pharmaceuticals Insider Sold Shares Worth $1,370,305, According to a Recent SEC Filing
ANI Pharmaceuticals Receives US FDA Approval for Indomethacin Oral Suspension
ANI Pharmaceuticals, Inc. Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USP
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIP Stock
  4. News ANI Pharmaceuticals, Inc.
  5. Other languages